Document Detail


Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
MedLine Citation:
PMID:  17418388     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
STUDY OBJECTIVE: To prospectively evaluate the repeat teen pregnancy rates, within one year of delivery, among adolescents who choose the contraceptive patch (Ortho Evra) versus oral contraceptive pills (OCP) versus Depot Medroxyprogesterone Acetate (Depo Provera, DMPA) for postpartum contraception. DESIGN: Observational, prospective cohort study. Comparison groups are postpartum teens, who self-select the contraceptive patch (n = 55) versus DMPA (n = 142) versus OCPs (n = 55) immediately postpartum. SETTING: Medical University of South Carolina, a tertiary medical center. PARTICIPANTS: Postpartum teens, 11-19 years old; 72% were African American, and 96% qualified for Medicaid insurance. INTERVENTIONS: A structured telephone interview was performed every 3 months. MAIN OUTCOME MEASURES: The primary outcome measure was a repeat pregnancy within 12 months of the index delivery. Secondary outcome variables were contraceptive continuation rates, reasons for discontinuation, side effects and condom usage. RESULTS: At 1-year follow-up, repeat pregnancy rates were 14.2%, 29.7%, and 31.8% among DMPA, OCP, and patch users respectively (P = 0.02). DMPA users were significantly more likely to be using any form of hormonal contraception 1 year postpartum than patch or OCP users. Condom use was similarly low among all cohorts. CONCLUSION: Adolescents who choose DMPA for postpartum contraception are significantly less likely to become pregnant within 1 year of delivery, as compared to teens who choose OCPs or the patch.
Authors:
Andrea Ries Thurman; Natalie Hammond; Helen E Brown; Mary Ellen Roddy
Related Documents :
6365448 - Immediate postplacental iud insertion: a randomized trial of sutured (lippes loop and t...
9220228 - Return of fertility after discontinuation of the once-a-month injectable contraceptive ...
6226488 - Multinational comparative clinical trial of long-acting injectable contraceptives: nore...
887128 - Fetal loss, twinning and birth weight after oral-contraceptive use.
2415888 - Neural tube defects: issues in prenatal diagnosis and counselling.
15910928 - The effect of age on multiple ovulation rates, multiple pregnancy rates and embryonic v...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of pediatric and adolescent gynecology     Volume:  20     ISSN:  1083-3188     ISO Abbreviation:  J Pediatr Adolesc Gynecol     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-09     Completed Date:  2007-06-13     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9610774     Medline TA:  J Pediatr Adolesc Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  61-5     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina, USA. thurmana@uthscsa.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Chi-Square Distribution
Child
Contraception Behavior*
Contraceptive Agents, Female / administration & dosage*
Contraceptives, Oral / administration & dosage*
Ethinyl Estradiol / administration & dosage*
Female
Humans
Medroxyprogesterone Acetate / administration & dosage*
Norgestrel / administration & dosage,  analogs & derivatives*
Postpartum Period
Pregnancy
Pregnancy in Adolescence* / prevention & control,  statistics & numerical data
Prospective Studies
Chemical
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Contraceptives, Oral; 0/Ortho Evra; 57-63-6/Ethinyl Estradiol; 6533-00-2/Norgestrel; 71-58-9/Medroxyprogesterone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Undescended ovaries: a clinical review.
Next Document:  Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of...